If approved, Novo Nordisk has indicated theyll have US manufacturing ready. Orforglipron is still completing its phase three trials, John adds, and results are expected in the first quarter of 2026
Reproductive effects : Potential impacts on fertility and reproductive health
Anti-inflammatory and glial effects In preclinical models, GLP-1R activation suppresses microglial activation and lowers central production of TNF-alpha, IL-1 beta, and IL-6
Probiotics, prebiotics and colorectal cancer prevention
Under the if-all-adhere estimand, participants on CagriSema achieved approximately 15.7% weight reduction at week 68, compared with approximately 3% for placebo
FAA is not pretending rescheduling already answers the operational safety question, and it is not ignoring rescheduling either